首页 > 市场调查报告书 > 製药

生物製剂

市场调查报告书

商品编码

1373935

生物工程蛋白药物市场，按药物类型、疾病、技术、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Bioengineered Protein Drugs Market, by Drugs Type, by Diseases, by Technology, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

出版日期: 2023年10月01日 | 出版商:

AnalystView Market Insights | 英文 289 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

报告要点

2022年生物工程蛋白药物市场规模为354,10022万美元，2023年至2030年复合CAGR为8.01%。

这些疗法在医学领域占有重要地位，因为它们能够精确地针对特定的生物过程，能够最大限度地减少不良反应，并有望改善患者的健康和整体福祉。

生物工程蛋白药物市场-市场动态

复杂且难以治疗的疾病的盛行率不断上升，推动了市场需求

复杂且难以治疗的疾病的日益流行极大地推动了对生物工程蛋白质药物的需求。自体免疫疾病、癌症和罕见遗传疾病等疾病通常需要高度针对性和个人化的治疗。生物工程蛋白质疗法，例如酵素替代物和单株抗体，是治疗这些疾病的精确而有效的解决方案的例证。

此外，生物技术和基因工程的进步使得更有效地生产这些疗法成为可能，从而降低了生产成本并提高了可近性。因此，对生物工程蛋白质疗法的需求不断增长，因为它们具有改善患者治疗效果和生活品质的潜力，加上对疾病根本原因的深入了解和客製化治疗的前景。

生物工程蛋白质药物市场 - 关键见解

根据我们的研究分析师提供的分析，预计2023年至2030年的预测期内，全球生物工程蛋白药物市场的年增长率约为8.01%。

生物工程蛋白药物行业有望实现显着增长，这主要是由复杂且难以治疗的疾病的日益流行所推动的。

从药物类型细分来看，2022年治疗酵素将成为市场的主导类别。

在疾病细分方面，糖尿病将在 2022 年成为主导细分市场。

从技术细分来看，2022年医药领域处于领先地位。

最后，就地区而言，北美地区脱颖而出，成为 2022 年的主要收入来源。

生物工程蛋白药物市场-細項分析：

全球生物工程蛋白药物市场根据药物类型、疾病、技术和地区进行细分。

就药物类型而言，市场涵盖一系列类别，包括胜肽激素、重组蛋白药物、治疗酵素、疫苗、细胞激素、单株抗体、胜肽抗生素、替代蛋白等。值得注意的是，由于治疗酶在治疗各种医疗状况方面的多功能性及其在个人化医疗中的潜在适用性，预计将引领生物工程蛋白药物产业。

生物工程蛋白药物市场-地理洞察

该市场横跨多个地理区域，包括北美、拉丁美洲、欧洲、亚太地区、中东和非洲。这些区域根据对市场做出贡献的国家进一步细分。

预计北美将主导市场，这主要是由于生物工程蛋白质治疗领域的重大技术进步和广泛的研究和开发努力，这有助于其在行业中的领导地位。

生物工程蛋白药物市场-竞争格局：

公司透过多种管道分销产品，包括公司网站、电子商务平台、零售店、分销合作伙伴和直接面向消费者的销售。这些产品製造商在多个维度中竞争，包括定价、产品性能、製造能力、分销管道、品牌声誉和产品可用性。

为了增强市场占有率并扩大市场份额，企业采用各种策略。这些策略包括推出新产品、扩大分销网络、投资研发以及参与併购。例如，2022 年 4 月，Satellite Bio 推出了一种创新的组织工程方法。该公司专注于再生医学、合成生物学、细胞生物学、细胞治疗和组织工程。

市场摘录
- 按药物类型分類的生物工程蛋白药物市场摘录
- 生物工程蛋白质药物市场摘录（按疾病）
- 生物工程蛋白药物市场摘录（依技术）
- 按国家/地区分類的生物工程蛋白药物市场摘录
- 按地区分類的生物工程蛋白药物市场摘录
竞争洞察

第 3 章：生物工程蛋白质药物主要市场趋势

生物工程蛋白药物市场驱动因素
- 市场驱动因素的影响分析
生物工程蛋白药物市场限制
- 市场限制影响分析
生物工程蛋白质药物的市场机会
生物工程蛋白药物市场未来趋势

第 4 章：生物工程蛋白药物产业研究

PEST分析
波特五力分析
成长前景图
规范架构分析

第 5 章：生物工程蛋白药物市场：COVID-19 影响分析

COVID-19 之前的影响分析
COVID-19 后影响分析
- 表现最佳的市场区隔
- 边际增长部分
- 最鬆散的部分
- 边际损失部分

第 6 章：生物工程蛋白药物市场格局

2022 年生物工程蛋白药物市场份额分析
按主要製造商分類的故障数据
- 既定玩家分析
- 新兴玩家分析

第 7 章：生物工程蛋白质药物市场 - 按药物类型

概述
- 按药物类型分類的细分市场份额分析
- 胜肽激素
- 重组蛋白药物
- 治疗酵素
- 疫苗
- 细胞因子
- 单株抗体
- 胜肽类抗生素
- 替代蛋白
- 其他的

第 8 章：生物工程蛋白质药物市场 - 依疾病分类

概述
- 按疾病分类的细分市场占有率分析
- 癌症
- 糖尿病
- 血液疾病
- 皮肤病
- 神经退化性疾病
- 心臟疾病
- 传染性疾病
- 呼吸疾病
- 其他的

第 9 章：生物工程蛋白质药物市场 - 按技术分类

概述
- 按技术分類的细分市场份额分析
- 生物反应器和微生物细胞发酵
- 分馏
- 基因改造生物
- 基因工程
- 网域嫁接
- 其他的

第 10 章：生物工程蛋白质药物市场 - 按地理位置

介绍
- 按地理位置分類的细分市场占有率分析
北美洲
- 概述
- 北美生物工程蛋白药物主要製造商
- 北美市场规模和预测（按国家）
- 北美市场规模和预测（按药物类型）
- 北美市场规模与预测（按疾病）
- 北美市场规模和预测（按技术）
- 我们
- 加拿大
欧洲
- 概述
- 欧洲生物工程蛋白药物主要製造商
- 欧洲市场规模和预测（按国家）
- 欧洲市场规模和预测（按药物类型）
- 欧洲市场规模与预测（按疾病）
- 欧洲市场规模与预测（按技术）
- 德国
- 义大利
- 英国
- 法国
- 俄罗斯
- 荷兰
- 瑞典
- 波兰
- 欧洲其他地区
亚太地区 (APAC)
- 概述
- 亚太地区生物工程蛋白药物主要製造商
- 亚太地区市场规模与预测（按国家）
- 亚太地区市场规模和预测（按药物类型）
- 亚太地区市场规模与预测（按疾病）
- 亚太地区市场规模与预测（按技术）
- 印度
- 中国
- 日本
- 韩国
- 澳洲
- 泰国
- 印尼
- 菲律宾
- 亚太地区其他地区
拉丁美洲
- 概述
- 拉丁美洲生物工程蛋白药物主要製造商
- 拉丁美洲市场规模与预测（按国家）
- 拉丁美洲市场规模与预测（按药物类型）
- 拉丁美洲市场规模与预测（按疾病）
- 拉丁美洲市场规模与预测（按技术）
- 巴西
- 墨西哥
- 阿根廷
- 哥伦比亚
- 拉丁美洲其他地区
中东和非洲
- 概述
- 中东和非洲生物工程蛋白质药物主要製造商
- 中东和非洲市场规模及预测（按国家）
- 中东和非洲市场规模及预测（按药物类型）
- 中东和非洲市场规模及预测（按疾病）
- 中东和非洲市场规模及预测（按技术）
- 沙乌地阿拉伯
- 阿拉伯聯合大公国
- 以色列
- 土耳其
- 阿尔及利亚
- 埃及
- MEA 的其余部分

第 11 章：主要供应商分析 - 生物工程蛋白药物产业

竞争仪表板
公司简介
- Vertex Pharmaceuticals
- Sanofi
- Regeneron Pharmaceuticals
- Pfizer
- Novo Nordisk
- Merck & Co.
- Johnson & Johnson (Janssen Pharmaceuticals)
- Gilead Sciences
- Genentech (Roche)
- Eli Lilly and Company
- Bristol-Myers Squibb
- Biogen
- AstraZeneca
- Amgen
- AbbVie

第 12 章：360 度分析师视角

第 13 章：附录

研究方法论
参考
缩写
免责声明
联络我们

简介目录图表

Product Code: ANV1810

REPORT HIGHLIGHT

Bioengineered Protein Drugs Market size was valued at USD 3,54,100.22 Million in 2022, expanding at a CAGR of 8.01% from 2023 to 2030.

Bioengineered protein therapeutics encompass medically valuable compounds generated through genetic engineering methodologies, often leveraging living organisms such as mammalian cells or bacteria to produce proteins with distinct therapeutic attributes. These medications emulate or enhance the functions of naturally occurring proteins within the body and are employed for the treatment of various medical conditions, including diabetes, cancer, and autoimmune disorders.

These therapeutics hold a significant place in the field of medicine due to their precision in targeting specific biological processes, their potential to minimize adverse effects, and their promise in improving the health and overall well-being of patients.

Bioengineered Protein Drugs Market- Market Dynamics

Increasing prevalence of complex and challenging-to-treat diseases to propel market demand

The demand for medications derived from bioengineered proteins is significantly propelled by the increasing prevalence of complex and challenging-to-treat diseases. Conditions such as autoimmune disorders, cancer, and rare genetic ailments often necessitate highly targeted and personalized treatments. Bioengineered protein therapeutics, such as enzyme replacements and monoclonal antibodies, exemplify precise and potent solutions for managing these disorders.

Furthermore, advancements in biotechnology and genetic engineering have made it possible to produce these therapeutics more efficiently, leading to reduced production costs and improved accessibility. Consequently, there is a growing demand for bioengineered protein therapeutics owing to their potential to enhance patient outcomes and quality of life, coupled with an enhanced understanding of the underlying causes of diseases and the promise of tailored treatments.

Bioengineered Protein Drugs Market- Key Insights

According to the analysis provided by our research analyst, the global market for Bioengineered Protein Drugs is expected to witness an annual growth rate of approximately 8.01% over the forecast period spanning from 2023 to 2030.

The Bioengineered Protein Drugs industry is poised for significant growth, primarily driven by the increasing prevalence of complex and challenging-to-treat diseases.

In terms of drug type segmentation, the year 2022 saw Therapeutic enzymes as the leading category in the market.

Regarding disease segmentation, Diabetes emerged as the dominant segment in 2022.

In terms of technology segmentation, Pharming was the leading category in 2022.

Finally, with respect to regions, North America stood out as the leading revenue generator in 2022.

Bioengineered Protein Drugs Market- Segmentation Analysis:

The Global Bioengineered Protein Drugs Market is segmented based on Drug Type, Disease, Technology, and Region.

In terms of Drug Type, the market encompasses a range of categories including Peptide hormones, Recombinant protein drugs, Therapeutic enzymes, Vaccines, Cytokines, Monoclonal antibodies, Peptide antibiotics, Replacement proteins, and Others. Notably, therapeutic enzymes are expected to lead the bioengineered protein drug industry due to their versatility in treating various medical conditions and their potential applicability in personalized medicine.

Bioengineered Protein Drugs Market- Geographical Insights

This market spans across various geographical regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented according to the countries contributing to the market.

North America is anticipated to dominate the market, primarily due to significant technological advancements and extensive research and development efforts in the field of bioengineered protein therapeutics, which have contributed to its leadership position in the industry.

Bioengineered Protein Drugs Market- Competitive Landscape:

Companies distribute their products through a variety of channels, which encompass corporate websites, e-commerce platforms, retail outlets, distribution partners, and direct-to-consumer sales. These product manufacturers engage in competition across several dimensions, including pricing, product performance, manufacturing capabilities, distribution channels, brand reputation, and product availability.

To enhance their market presence and expand their market share, businesses employ various strategies. These strategies encompass launching new products, expanding their distribution networks, investing in research and development, and engaging in mergers and acquisitions. As an example, in April 2022, Satellite Bio introduced an innovative approach to tissue engineering. This company specializes in regenerative medicine, synthetic biology, cell biology, cell therapy, and tissue engineering.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET KEY PLAYERS

Vertex Pharmaceuticals
Sanofi
Regeneron Pharmaceuticals
Pfizer
Novo Nordisk
Merck & Co.
Johnson & Johnson (Janssen Pharmaceuticals)
Gilead Sciences
Genentech (Roche)
Eli Lilly and Company
Bristol-Myers Squibb
Biogen
AstraZeneca
Amgen
AbbVie

GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET, BY DRUG TYPE

Peptide hormones
Recombinant protein drugs
Therapeutic enzymes
Vaccines
Cytokines
Monoclonal antibodies
Peptide antibiotics
Replacement proteins
Others

GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET, BY DISEASES

Cancer
Diabetes
Blood disorders
Skin diseases
Neurodegenerative diseases
Heart diseases
Infectious diseases
Respiratory diseases
Others

GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET, BY TECHNOLOGY

Bioreactors and Microbial Cell Fermentation
Fractionation
Genetically Modified Organisms
Genetic Engineering
Pharming
Others

GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET, BY REGION

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Bioengineered Protein Drugs Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Bioengineered Protein Drugs Market Snippet by Drug Type
- 2.1.2. Bioengineered Protein Drugs Market Snippet by Diseases
- 2.1.3. Bioengineered Protein Drugs Market Snippet by Technology
- 2.1.4. Bioengineered Protein Drugs Market Snippet by Country
- 2.1.5. Bioengineered Protein Drugs Market Snippet by Region
2.2. Competitive Insights

3. Bioengineered Protein Drugs Key Market Trends

3.1. Bioengineered Protein Drugs Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Bioengineered Protein Drugs Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Bioengineered Protein Drugs Market Opportunities
3.4. Bioengineered Protein Drugs Market Future Trends

4. Bioengineered Protein Drugs Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Bioengineered Protein Drugs Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Bioengineered Protein Drugs Market Landscape

6.1. Bioengineered Protein Drugs Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Bioengineered Protein Drugs Market - By Drug Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Drug Type, 2022 & 2030 (%)
- 7.1.2. Peptide hormones
- 7.1.3. Recombinant protein drugs
- 7.1.4. Therapeutic enzymes
- 7.1.5. Vaccines
- 7.1.6. Cytokines
- 7.1.7. Monoclonal antibodies
- 7.1.8. Peptide antibiotics
- 7.1.9. Replacement proteins
- 7.1.10. Others

8. Bioengineered Protein Drugs Market - By Diseases

8.1. Overview
- 8.1.1. Segment Share Analysis, By Diseases, 2022 & 2030 (%)
- 8.1.2. Cancer
- 8.1.3. Diabetes
- 8.1.4. Blood disorders
- 8.1.5. Skin diseases
- 8.1.6. Neurodegenerative diseases
- 8.1.7. Heart diseases
- 8.1.8. Infectious diseases
- 8.1.9. Respiratory diseases
- 8.1.10. Others

9. Bioengineered Protein Drugs Market - By Technology

9.1. Overview
- 9.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
- 9.1.2. Bioreactors and Microbial Cell Fermentation
- 9.1.3. Fractionation
- 9.1.4. Genetically Modified Organisms
- 9.1.5. Genetic Engineering
- 9.1.6. Pharming
- 9.1.7. Others

10. Bioengineered Protein Drugs Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Bioengineered Protein Drugs Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Bioengineered Protein Drugs Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Bioengineered Protein Drugs Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Bioengineered Protein Drugs Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Bioengineered Protein Drugs Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Bioengineered Protein Drugs Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Vertex Pharmaceuticals
- 11.2.2. Sanofi
- 11.2.3. Regeneron Pharmaceuticals
- 11.2.4. Pfizer
- 11.2.5. Novo Nordisk
- 11.2.6. Merck & Co.
- 11.2.7. Johnson & Johnson (Janssen Pharmaceuticals)
- 11.2.8. Gilead Sciences
- 11.2.9. Genentech (Roche)
- 11.2.10. Eli Lilly and Company
- 11.2.11. Bristol-Myers Squibb
- 11.2.12. Biogen
- 11.2.13. AstraZeneca
- 11.2.14. Amgen
- 11.2.15. AbbVie

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us

简介目录图表

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Bioengineered Protein Drugs Market: Drug Type Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Drug Type
TABLE Global Bioengineered Protein Drugs Market, by Drug Type 2018-2030 (USD Million)
TABLE Bioengineered Protein Drugs Market: Diseases Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Diseases
TABLE Global Bioengineered Protein Drugs Market, by Diseases 2018-2030 (USD Million)
TABLE Bioengineered Protein Drugs Market: Technology Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Technology
TABLE Global Bioengineered Protein Drugs Market, by Technology 2018-2030 (USD Million)
TABLE Bioengineered Protein Drugs Market: Regional snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Bioengineered Protein Drugs Market, by Region 2018-2030 (USD Million)
TABLE North America Bioengineered Protein Drugs Market, by Country, 2018-2030 (USD Million)
TABLE North America Bioengineered Protein Drugs Market, by Drug Type, 2018-2030 (USD Million)
TABLE North America Bioengineered Protein Drugs Market, by Diseases, 2018-2030 (USD Million)
TABLE North America Bioengineered Protein Drugs Market, by Technology, 2018-2030 (USD Million)
TABLE Europe Bioengineered Protein Drugs Market, by Country, 2018-2030 (USD Million)
TABLE Europe Bioengineered Protein Drugs Market, by Drug Type, 2018-2030 (USD Million)
TABLE Europe Bioengineered Protein Drugs Market, by Diseases, 2018-2030 (USD Million)
TABLE Europe Bioengineered Protein Drugs Market, by Technology, 2018-2030 (USD Million)
TABLE Asia Pacific Bioengineered Protein Drugs Market, by Country, 2018-2030 (USD Million)
TABLE Asia Pacific Bioengineered Protein Drugs Market, by Drug Type, 2018-2030 (USD Million)
TABLE Asia Pacific Bioengineered Protein Drugs Market, by Diseases, 2018-2030 (USD Million)
TABLE Asia Pacific Bioengineered Protein Drugs Market, by Technology, 2018-2030 (USD Million)
TABLE Latin America Bioengineered Protein Drugs Market, by Country, 2018-2030 (USD Million)
TABLE Latin America Bioengineered Protein Drugs Market, by Drug Type, 2018-2030 (USD Million)
TABLE Latin America Bioengineered Protein Drugs Market, by Diseases, 2018-2030 (USD Million)
TABLE Latin America Bioengineered Protein Drugs Market, by Technology, 2018-2030 (USD Million)
TABLE Middle East and Africa Bioengineered Protein Drugs Market, by Country, 2018-2030 (USD Million)
TABLE Middle East and Africa Bioengineered Protein Drugs Market, by Drug Type, 2018-2030 (USD Million)
TABLE Middle East and Africa Bioengineered Protein Drugs Market, by Diseases, 2018-2030 (USD Million)
TABLE Middle East and Africa Bioengineered Protein Drugs Market, by Technology, 2018-2030 (USD Million)

List of Figures

FIGURE Bioengineered Protein Drugs Market Segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter's Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE COVID-19 Impact Analysis
FIGURE Pre & Post COVID-19 Impact Comparision Study
FIGURE Competitive Landscape; Key company market share analysis, 2022
FIGURE Drug Type segment market share analysis, 2022 & 2030
FIGURE Drug Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Diseases segment market share analysis, 2022 & 2030
FIGURE Diseases segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Technology segment market share analysis, 2022 & 2030
FIGURE Technology segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Regional segment market share analysis, 2022 & 2030
FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE North America Bioengineered Protein Drugs Market share and leading players, 2022
FIGURE Europe Bioengineered Protein Drugs Market share and leading players, 2022
FIGURE Asia Pacific Bioengineered Protein Drugs Market share and leading players, 2022
FIGURE Latin America Bioengineered Protein Drugs Market share and leading players, 2022
FIGURE Middle East and Africa Bioengineered Protein Drugs Market share and leading players, 2022
FIGURE North America market share analysis by country, 2022
FIGURE U.S. Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Canada Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Europe Bioengineered Protein Drugs Market share analysis by country, 2022
FIGURE Germany Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Spain Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Italy Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE France Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE UK Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Russia Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Netherlands Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Sweden Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Poland Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of the Europe Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Asia Pacific Bioengineered Protein Drugs Market share analysis by country, 2022
FIGURE India Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE China Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Japan Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE South Korea Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Australia Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Thailand Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Indonesia Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Phillipines Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of APAC Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Latin America Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Latin America Bioengineered Protein Drugs Market share analysis by country, 2022
FIGURE Brazil Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Mexico Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Argentina Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Colombia Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of LATAM Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Middle East and Africa Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Middle East and Africa Bioengineered Protein Drugs Market share analysis by country, 2022
FIGURE Saudi Arabia Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE United Arab Emirates Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Israel Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Turkey Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Algeria Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Egypt Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of MEA Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)